/var/www/html/apps.und.edu/uletterarchive/print_article.php:22:
array (size=8)
  'HEADLINE' => string 'IBC lists policy for biohazardous materials' (length=43)
  'MESSAGE' => string 'The Institutional Biosafety Committee (IBC) requires that any research, teaching, or other activities which utilize DNA, recombinant DNA or involve the use of biohazardous research material be subject to a University review process, and that these activities must be approved by the IBC prior to their initiation. The IBC is the only authorized University committee which can give approval to projects and activities involving DNA, recombinant DNA and biohazardous research material. The IBC will follow the NIH '... (length=2257)
  'NAME' => string 'Thomas Hill, Ph.D.' (length=18)
  'TITLE' => string 'Chair, Institutional Biosafety Committee' (length=40)
  'DEPT' => string 'Microbiology and Immunology' (length=27)
  'EMAIL' => string 'tomhill@medicine.nodak.edu' (length=26)
  'PHONE' => string '777-6412' (length=8)
  'SIGNED' => string '1' (length=1)
IBC lists policy for biohazardous materials


The Institutional Biosafety Committee (IBC) requires that any research, teaching, or other activities which utilize DNA, recombinant DNA or involve the use of biohazardous research material be subject to a University review process, and that these activities must be approved by the IBC prior to their initiation. The IBC is the only authorized University committee which can give approval to projects and activities involving DNA, recombinant DNA and biohazardous research material. The IBC will follow the NIH guidelines for DNA, recombinant DNA and biohazardous material research in determining the suitability of projects and activities and will provide an explanation of any decision not to approve a project or activity. Any project or activity not approved can be revised and resubmitted to the IBC for consideration.

All faculty or staff who plan on using recombinant DNA, biohazardous materials or conducting activities that involve the handling of biological materials in a research setting (live or dead animals, plant or animal pathogens, tissue, blood, bodily secretions, nucleic acids, toxins, etc.), teaching, or other activities must submit a completed, signed application form to the IBC Office, University of North Dakota, Twamley Hall Room 106, 264 Centennial Drive Stop 7134, Grand Forks, ND 58202-7134. The IBC will then consider the application at its earliest convenience.

One copy of all funded grant applications utilizing recombinant DNA or biohazardous materials must be submitted to the IBC. The PI will not be able to access grant funds or begin the project until the IBC has reviewed and approved the project. Any changes to an approved project must receive IBC approval prior to their implementation.

Anyone considering the use of DNA, recombinant DNA, or biohazardous materials should contact the Research Development and Compliance (RD&C) office at the address listed above or call the IBC administrative secretary at 777-4279 for a copy of the NIH guidelines, the IBC application form and other pertinent information. Forms and information are also available on the IBC web site at http://www.und.edu/dept/rdc/regucomm/ibc/ibc.htm.
-- Thomas Hill, Ph.D., Chair, Institutional Biosafety Committee, Microbiology and Immunology, tomhill@medicine.nodak.edu, 777-6412